Operating Expenses (Quarterly)

Operating Expenses: The sum of all operating expenses for the given industry.

Fortress Biotech, Inc. (FBIO) had Operating Expenses of $52.89M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$16.41M
Net Income	$13.36M
Cost of Goods Sold	$4.94M
Gross Profit	$11.47M
Operating Expenses	$52.89M
Operating Income	$-36.47M
Non-Operating Income/Expense	$24.82M
Pre-Tax Income	$-11.65M
Normalized Pre-Tax Income	$-11.65M
Income after Taxes	$-11.65M
Income from Continuous Operations	$-11.65M
Consolidated Net Income/Loss	$-11.65M
Normalized Income after Taxes	$-11.65M
EBIT	$-36.47M
EBITDA	$-34.38M
Weighted-Average Shares Outstanding (Basic)	26.88M
Weighted-Average Shares Outstanding (Diluted)	29.82M
Earnings per Share (EPS) (Basic)	$0.50
Earnings per Share (EPS) (Diluted)	$0.45
Balance Sheet Financials
Current Assets	$110.40M
Property, Plant, and Equipment	$2.70M
Long-Term Assets	$49.50M
Total Assets	$159.90M
Current Liabilities	$57.52M
Long-Term Debt	$50.03M
Long-Term Liabilities	$64.99M
Total Liabilities	$122.51M
Common Equity	$37.38M
Tangible Shareholders Equity	$7.65M
Shareholders Equity	$37.38M
Common Shares Outstanding	29.75M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-47.12M
Cash Flow from Investing Activities	$7.25M
Cash Flow from Financial Activities	$56.66M
Beginning Cash	$58.81M
End Cash	$75.61M
Increase/Decrease in Cash	$16.79M
Stock-Based Compensation	$23.08M
Common Stock Dividends Paid	$-0.33M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.57
Debt to Equity Ratio	1.44
Gross Margin	69.91%
Operating Margin	-222.22%
EBIT Margin	-222.22%
EBITDA Margin	--
Pre-Tax Profit Margin	-71.00%
Profit Margin	81.37%
Free Cash Flow	$-45.96M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.38
Receiveable Turnover	1.01
Days Sales in Receivables	88.84
Return on Equity	-31.18%
Return on Tangible Equity	-152.36%
Return on Assets	-7.29%
Return on Investments	-13.33%
Book Value Per Share	$1.26
Free Cash Flow per Share	$-1.54
Operating Cash Flow per Share	$-1.58

Data from Zacks Investment Research, Inc.